Key Takeaways
- Geopolitical risk spiked as Iran launched a new wave of missiles at Israel, prompting Kuwaiti air defenses to activate and sending S&P 500 and Nasdaq futures down 0.1% in early trade.
- Gilead Sciences (GILD) announced a definitive agreement to acquire Ouro Medicines for $1.675 billion in upfront cash, targeting first-in-class T cell engager programs for autoimmune diseases.
- Australia’s economy signaled a sharp downturn as the Flash Composite PMI plunged into contraction at 47.0, while weekly consumer inflation expectations surged to a record 6.9%.
- NextEra Energy (NEE) is expanding its infrastructure to meet AI demand, securing land in Texas for a major gas plant specifically designed to power data centers.
- Energy markets face volatility as the New Zealand central bank warned of potential rate hikes due to protracted energy shocks, while the U.S. explores additional Alaska drilling.
Geopolitical Escalation in the Middle East
Global markets are on edge following reports from Iran’s state broadcaster, IRIB, that Tehran has fired a new wave of missiles at Israel. The escalation has drawn in regional neighbors, with the Kuwaiti Army General Staff confirming that its air defense systems are actively working to confront Iranian missile activity.
The conflict is further complicated by allegations from Ukrainian President Volodymyr Zelenskyy, who claimed to have "irrefutable" evidence that Russia is providing intelligence to Iran. Meanwhile, North Korean leader Kim Jong Un declared the nation's nuclear status "irreversible," adding to a climate of heightened global instability.
Gilead Sciences Bolsters Autoimmune Portfolio
In a major healthcare move, Gilead Sciences (GILD) has agreed to acquire Ouro Medicines to advance a first-in-class T cell engager program. Beyond the $1.675 billion upfront payment, Ouro shareholders are eligible for up to $500 million in contingent milestone payments.
The deal involves a heavy collaboration with Galapagos (GLPG), which will cover 50% of the upfront and milestone payments. While Gilead retains sole global commercialization rights outside of Greater China, it will pay Galapagos (GLPG) royalties ranging from 20% to 23% on net sales.
Australian Economic Indicators Flash Red
Australia's economic outlook darkened significantly as S&P Global reported the Flash Composite PMI plunged to 47.0 in March, down from 52.4 in February. The services sector saw the most dramatic slump, falling to 46.6, indicating a sharp contraction in business activity.
Consumer sentiment has mirrored this decline, with ANZ-Roy Morgan reporting that consumer confidence dropped to 63.1, its lowest level since 1973. This collapse in confidence comes as inflation expectations surged to 6.9%, a record high that complicates the path forward for regional monetary policy.
Energy and Infrastructure Developments at CERAWeek
At the CERAWeek energy conference, NextEra Energy (NEE) CEO announced the company has secured land in Texas for a new gas-fired power plant. The facility is intended to provide dedicated power to data centers, highlighting the massive energy requirements of the growing AI sector.
Simultaneously, White House energy advisers indicated that U.S. oil firms are exploring additional drilling in Alaska. The administration is also urging the European Union to revise methane rules to facilitate smoother U.S.-EU energy trade, as Western nations seek to stabilize energy security amid ongoing Middle Eastern volatility.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.